Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)

A western lifestyle, characterised by low rates of energy expenditure and a high-energy diet rich in animal protein, saturated fats and refined carbohydrates, is associated with high incidence of prostate cancer in men. A high-energy nutritional status results in insulin/IGF signalling in cells, whi...

Full description

Bibliographic Details
Main Authors: Campa, D, Hüsing, A, Chang-Claude, J, Dostal, L, Boeing, H, Kröger, J, Tjønneland, A, Roswall, N, Overvad, K, Dahm, C, Rodríguez, L, Sala, N, Pérez, M, Larrañaga, N, Chirlaque, M, Ardanaz, E, Khaw, K, Wareham, N, Allen, N, Travis, R, Trichopoulou, A, Naska, A, Bamia, C, Palli, D, Sieri, S
Format: Journal article
Language:English
Published: 2011
_version_ 1797086032362995712
author Campa, D
Hüsing, A
Chang-Claude, J
Dostal, L
Boeing, H
Kröger, J
Tjønneland, A
Roswall, N
Overvad, K
Dahm, C
Rodríguez, L
Sala, N
Pérez, M
Larrañaga, N
Chirlaque, M
Ardanaz, E
Khaw, K
Wareham, N
Allen, N
Travis, R
Trichopoulou, A
Naska, A
Bamia, C
Palli, D
Sieri, S
author_facet Campa, D
Hüsing, A
Chang-Claude, J
Dostal, L
Boeing, H
Kröger, J
Tjønneland, A
Roswall, N
Overvad, K
Dahm, C
Rodríguez, L
Sala, N
Pérez, M
Larrañaga, N
Chirlaque, M
Ardanaz, E
Khaw, K
Wareham, N
Allen, N
Travis, R
Trichopoulou, A
Naska, A
Bamia, C
Palli, D
Sieri, S
author_sort Campa, D
collection OXFORD
description A western lifestyle, characterised by low rates of energy expenditure and a high-energy diet rich in animal protein, saturated fats and refined carbohydrates, is associated with high incidence of prostate cancer in men. A high-energy nutritional status results in insulin/IGF signalling in cells, which in turn stimulates synthesis of fatty acids. We investigated whether the genetic variability of the genes belonging to the fatty acid synthesis pathway is related to prostate cancer risk in 815 prostate cancer cases and 1266 controls from the European Prospective Investigation on Cancer (EPIC). Using a tagging approach and selecting 252 SNPs in 22 genes, we covered all the common genetic variation of this pathway. None of the SNPs reached statistical significance after adjusting for multiple comparisons. Common SNPs in the fatty acid synthase pathway are not major contributors to prostate cancer risk. © 2010 Elsevier Ltd. All rights reserved.
first_indexed 2024-03-07T02:16:14Z
format Journal article
id oxford-uuid:a252b53d-b770-4993-b098-bff36683800b
institution University of Oxford
language English
last_indexed 2024-03-07T02:16:14Z
publishDate 2011
record_format dspace
spelling oxford-uuid:a252b53d-b770-4993-b098-bff36683800b2022-03-27T02:19:33ZGenetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a252b53d-b770-4993-b098-bff36683800bEnglishSymplectic Elements at Oxford2011Campa, DHüsing, AChang-Claude, JDostal, LBoeing, HKröger, JTjønneland, ARoswall, NOvervad, KDahm, CRodríguez, LSala, NPérez, MLarrañaga, NChirlaque, MArdanaz, EKhaw, KWareham, NAllen, NTravis, RTrichopoulou, ANaska, ABamia, CPalli, DSieri, SA western lifestyle, characterised by low rates of energy expenditure and a high-energy diet rich in animal protein, saturated fats and refined carbohydrates, is associated with high incidence of prostate cancer in men. A high-energy nutritional status results in insulin/IGF signalling in cells, which in turn stimulates synthesis of fatty acids. We investigated whether the genetic variability of the genes belonging to the fatty acid synthesis pathway is related to prostate cancer risk in 815 prostate cancer cases and 1266 controls from the European Prospective Investigation on Cancer (EPIC). Using a tagging approach and selecting 252 SNPs in 22 genes, we covered all the common genetic variation of this pathway. None of the SNPs reached statistical significance after adjusting for multiple comparisons. Common SNPs in the fatty acid synthase pathway are not major contributors to prostate cancer risk. © 2010 Elsevier Ltd. All rights reserved.
spellingShingle Campa, D
Hüsing, A
Chang-Claude, J
Dostal, L
Boeing, H
Kröger, J
Tjønneland, A
Roswall, N
Overvad, K
Dahm, C
Rodríguez, L
Sala, N
Pérez, M
Larrañaga, N
Chirlaque, M
Ardanaz, E
Khaw, K
Wareham, N
Allen, N
Travis, R
Trichopoulou, A
Naska, A
Bamia, C
Palli, D
Sieri, S
Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title_full Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title_fullStr Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title_full_unstemmed Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title_short Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
title_sort genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the european prospective investigation on cancer epic
work_keys_str_mv AT campad geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT husinga geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT changclaudej geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT dostall geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT boeingh geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT krogerj geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT tjønnelanda geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT roswalln geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT overvadk geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT dahmc geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT rodriguezl geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT salan geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT perezm geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT larranagan geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT chirlaquem geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT ardanaze geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT khawk geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT warehamn geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT allenn geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT travisr geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT trichopouloua geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT naskaa geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT bamiac geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT pallid geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic
AT sieris geneticvariabilityofthefattyacidsynthasepathwayisnotassociatedwithprostatecancerriskintheeuropeanprospectiveinvestigationoncancerepic